When: $1,070-$1,090 (200 SMA zone) with bullish reversal confirmation

Then: Add-on tranche

HOLD with existing positions; tightened stops at $1,050; wait for confirmed entry trigger at 10 EMA reclaim ($1,143.91) with MACD histogram contraction and RSI hooking up from below 40

• Probability-weighted scenarios: 30% bull case $1,500-$1,650, 50% base case $1,100-$1,250, 20% bear case $850-$950
• Expected value from $1,138 entry: bull ~$131, base flat to slightly negative, bear -$48, total ~$80
• Hard stop loss of $83 (from $1,138 entry) nearly equals entire expected value of ~$80
• Stop placed at $1,055, seven dollars below the 200 SMA at $1,062 — creates internal inconsistency in thesis
• MACD cross below zero is six sessions old; histogram moving from -5.67 to -7.72 in four sessions — momentum actively deteriorating
• LLY fundamentals: 102% ROE, 54% operating margins, accelerating revenue
• LLY valuation: 38x trailing earnings, 24x forward P/E
• 10-year Treasury at multiyear highs; Polymarket pricing 94% odds of zero Fed cuts in 2026
• 10% multiple compression from 24x to 21.6x forward P/E would shave ~$113 off stock — larger than entire stop loss
• 50% probability of range-bound action, 20% probability of meaningful downside per probability-weighted scenarios
• Entry trigger: 10 EMA reclaim at $1,143.91 with contracting MACD histogram and RSI hooking up from below 40

→ vs aggressive: Reward-to-risk ratio of 4.4-to-1 to 6.2-to-1 is based on sell-side target (marketing material), not probability-weighted scenarios yielding only ~$80 expected value against $83 stop

→ vs aggressive: Stop placement at $1,055 contradicts claim that 200 SMA at $1,062 is a major structural floor — cannot claim both that it will hold and place stop below it

→ vs aggressive: MACD will turn positive before price is false generalization that ignores confirmed bearish cross with building downside thrust (histogram -5.67 to -7.72 in four sessions)

→ vs aggressive: Orderly decline is not automatically bullish — such declines can persist for weeks/months; buying now contradicts bear's own timing concerns

→ vs aggressive: Competitive narrative (LLY vs NVO) does not hedge against multiple compression, drug pricing legislation, manufacturing execution risk, or regulatory tail risks (WSJ reporting unapproved LLY drug versions flooding a US state)

→ vs aggressive: Beta of 0.50 protects against market beta but not fundamental re-rating risk from high P/E at rising discount rates

→ vs aggressive: WSB silence on 12% pullback is not evidence of bull case — equally supports 'retail leaning cautious' interpretation; reading bullish narrative is confirmation bias

→ vs aggressive: Framing 'biggest risk is not being long enough' is dangerous — primary mandate is capital preservation; cash is a position with better risk-adjusted returns at confirmed reversal

OVERWEIGHT with conservative staged entry (25-30% initial position vs original 40-50% proposal)

• Probability-weighted upside somewhere between 80 and 130 dollars at 1138 with defined downside of 83 dollars; not 4-to-1 asymmetry but modestly positive expected value setup
• Deteriorating momentum: MACD cross below zero is six sessions old, histogram moving from negative 5.67 to negative 7.72 over four sessions indicating actively accelerating bearish momentum
• 200 SMA at 1062 is probabilistic support, not absolute floor; stop at 1055 gives level room to breathe but aggressive analyst should stop claiming it as structural support
• Orderliness of decline supports consolidation within uptrend: September 11 low held above Bollinger lower band at 1081, RSI at 42 neutral-to-weak but not panicking
• Macro headwind real but slow grind not cliff: 10Y at multiyear highs and 94 percent probability of no Fed cuts in 2026, but 10 percent multiple compression scenario shaves about 113 dollars
• Beta of 0.50 means LLY already trades defensively; FCF inflection from 6 billion to 11 billion TTM supports multiple holding rather than compressing
• Morgan Stanley downgrade of NVO, corporate rebrand, 12 percent YTD decline and 50 percent loss in 2025 suggests competitive landscape has shifted decisively in LLY's favor
• Add-on triggers: (1) daily close above 10 EMA at 1143.91 with MACD histogram contracting for two consecutive sessions and RSI hooking up from below 45; (2) controlled pullback into 1081 to 1116 zone only if MACD histogram at least neutral
• WSB silence point: cannot distinguish between retail being uninterested versus cautious; absence of data is not strong evidence for any thesis

→ vs aggressive: Sell-side targets are systematically optimistic; anchoring on one bank's 45 percent upside as base case is wrong—the aggressive analyst should not claim 4.4 to 1 to 6.2 to 1 reward-to-risk ratio when that 45 percent is the bank's own bull case

→ vs aggressive: MACD will turn positive before price is a generalization with exceptions, and one of those exceptions is fresh, accelerating bearish crosses that are six sessions old with histogram expanding negative

→ vs aggressive: Cannot dismiss LLY drawdown history as sample-size fallacy when current setup has unresolved technical levels that historically take time to clear

→ vs conservative: Bear case treated as more credible than fundamentals warrant; the honest probability-weighted upside is 80 to 130 dollars, not a coin flip

→ vs conservative: Orderliness of decline matters—structural floor hasn't been tested; this is consolidation within an uptrend, not a breakdown

→ vs conservative: Higher-for-longer narrative is consensus; consensus narratives rarely resolve in single catalyst event, arguing for position sizing that respects risk without abandoning structural thesis